ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ORGS Orgenesis Inc

0.5072
0.00 (0.00%)
Pre Market
Last Updated: 04:16:34
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Orgenesis Inc ORGS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.5072 04:16:34
Open Price Low Price High Price Close Price Prev Close
0.5072
more quote information »

Recent News

Date Time Source Heading
4/22/20248:49IHNWFeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
4/15/202417:07GLOBEOrgenesis Provides Year End Business Update
4/10/202412:00GLOBEGermfree and Orgenesis Announce Asset Purchase and Strategic..
3/18/202408:30GLOBEVered Caplan, CEO of Orgenesis, to Present at the..
3/13/202408:30GLOBEOrgenesis Consortium Awarded €1.5M EUR Grant from the..
3/04/202408:30GLOBEOrgenesis Inc. Announces $2.3 Million Private Placement
2/29/202408:30GLOBEOrgenesis Consortium Awarded €2.0M EUR Grant from Walloon..
1/31/202409:20EDGAR2Form 8-K - Current report
1/31/202409:15GLOBEOrgenesis Acquires Control of Octomera with the Goal of..
1/24/202416:05EDGAR2Form 8-K - Current report
1/22/202416:01EDGAR2Form 8-K - Current report
1/08/202417:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202417:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/05/202406:02EDGAR2Form 8-K - Current report
11/14/202308:30GLOBEOrgenesis Ranked No. 171st Fastest-Growing Company in North..
11/13/202316:15GLOBEOrgenesis Provides Business Update for the Third Quarter of..
11/09/202307:41EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/08/202309:24EDGAR2Form 8-K - Current report
11/08/202309:00GLOBEOrgenesis Inc. Announces Pricing of $1.1 Million Registered..
11/02/202308:00GLOBEOrgenesis Announces Expanded Partnership Between Octomera..
10/30/202321:30GLOBEOrgenesis Announces Withdrawal of Proposed Public Offering
10/30/202316:07GLOBEOrgenesis Announces Proposed Underwritten Public Offering
9/21/202308:00GLOBECGT Global and Octomera Enter Agreement to Expand Cell &..
9/06/202307:00GLOBECell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard..
9/05/202316:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/11/202307:00GLOBEOrgenesis Provides Business Update for Second Quarter of..
8/10/202317:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202308:30GLOBEOrgenesis Schedules Second Quarter 2023 Business Update..
7/13/202308:30GLOBEOrgenesis Appoints Finance Veteran Elliot Maltz as its Chief..
7/12/202316:05EDGAR2Form 8-K - Current report
7/11/202307:00GLOBEOrgenesis Announces Name Change of Morgenesis Business Unit..
6/07/202307:00GLOBEOrgenesis and University of California, Davis Sign..
5/30/202309:30GLOBEClaudia Zylberberg Appointed as Independent Board Member of..
5/22/202307:30GLOBEOrgenesis Academy Graduates First Class of Cell and Gene..
5/19/202308:30GLOBEOrgenesis to Participate in Benchmark’s 3rd Annual..
5/18/202307:30GLOBEOrgenesis Announces Collaboration Agreement with SCTbio to..
5/10/202316:30GLOBEOrgenesis Provides Business Update for the First Quarter of..
5/10/202310:00GLOBEOrgenesis Secures an Additional $5 Million Investment from..
4/25/202308:30GLOBEOrgenesis CEO Vered Caplan Featured in Keynote Series at..

Your Recent History

Delayed Upgrade Clock